USDM delivered restructured data systems while ensuring continuous compliance and reduced risk
Learn how USDM saved a biopharma company with $30B in annual revenue more than $500k in licensing fees by implementing Salesforce GxP capabilities, which created baseline and automated testing as well as risk-based validation.
- Leading biopharma company with more than $30B in annual revenue
- Dozens of platforms used by more than 8,000 employees
- Entrenched belief that Salesforce could not be used in a qualified way
- Minimal cloud adoption for GxP use cases
- No compliance framework for assessing and maintaining a validated state for cloud based applications